Takeaway
- In younger, newly diagnosed multiple myeloma (NDMM) patients, early use of autologous stem cell transplant (ASCT) led to significant gains in progression-free survival (PFS) compared to the absence of an initial transplant.
- ASCT timing did not influence the overall survival (OS).
- Adverse events are more common with ASCT.
...
